MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM
Open Access
- 30 April 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 23 (10), 1744-1754
- https://doi.org/10.1038/leu.2009.80
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- How do BCL-2 proteins induce mitochondrial outer membrane permeabilization?Trends in Cell Biology, 2008
- The Bcl-2 apoptotic switch in cancer development and therapyOncogene, 2007
- Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cellsApoptosis, 2006
- Bim and Bad mediate imatinib-induced killing of Bcr/Abl + leukemic cells, and resistance due to their loss is overcome by a BH3 mimeticProceedings of the National Academy of Sciences of the United States of America, 2006
- Blockade of the ERK pathway markedly sensitizes tumor cells to HDAC inhibitor-induced cell deathBiochemical and Biophysical Research Communications, 2006
- Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibitionNature Structural & Molecular Biology, 2004
- Cell Death: Critical Control PointsCell, 2004
- Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPKNature, 2003
- Glucocorticoid-Induced Apoptosis in LymphocytesBiochemical and Biophysical Research Communications, 2000
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000